Molecular Insight names 4 new directors to board
Biotechnology company Molecular Insight Pharmaceuticals Inc. has added four new directors to its board, including employees of GlaxoSmithKline PLC and Novartis AG, the Associated Press reported. The company named David Epstein, Dr. Yvonne Greenstreet, Joseph Limber and Dr. Anthony Martin to the board. Epstein is president and chief executive of Novartis Oncology, and Greenstreet is senior vice president and chief of research and development strategy for GlaxoSmithKline. Limber is president and CEO of Prometheus Laboratories, Inc., a specialty pharmaceutical and diagnostics company. Martin is a founder and managing partner of TMA Consultants, which offers consulting and management services to biotechnology and life sciences companies.